TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute June 21, 1996
TCL Archive Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation August 29, 2014
TCL Archive NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive” June 11, 2010
